お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:e薬局
市場調査レポート
商品コード
615488

e薬局

ePharmacies

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 153 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=109.66円

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

e薬局
出版日: 2021年04月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 153 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界のe薬局 (ePharmacies) 市場の規模 (金額ベース) 、主要国/地域別の市場規模推計・予測、市場データ分析、および主要企業のプロファイルなどをまとめています。

第1章 イントロダクション、調査方法、製品の定義

第2章 エグゼクティブサマリー

  • 産業概要
  • 市場動向・促進因子・課題
  • サービス概要
  • 近年の産業活動
  • 主要企業へのフォーカス
  • 世界市場の展望

第3章 市場

  • 米国
  • カナダ
  • 欧州
    • ドイツ
    • 英国
    • その他
  • アジア太平洋地域
    • 中国
    • その他
  • 中東・アフリカ
  • ラテンアメリカ
目次
Product Code: MCP-6829

Abstract:

Global ePharmacies Market to Reach $169.6 Billion by 2027

Amid the COVID-19 crisis, the global market for ePharmacies estimated at US$56.9 Billion in the year 2020, is projected to reach a revised size of US$169.6 Billion by 2027, growing at aCAGR of 16.9% over the period 2020-2027. Over-the-Counter Products, one of the segments analyzed in the report, is projected to record 16.5% CAGR and reach US$110.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Prescription Medicine segment is readjusted to a revised 17.6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $16.9 Billion, While China is Forecast to Grow at 16.3% CAGR

The ePharmacies market in the U.S. is estimated at US$16.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$29.4 Billion by the year 2027 trailing a CAGR of 16.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 15% and 14.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.4% CAGR.

Select Competitors (Total 69 Featured) -

  • 1mg Technologies Pvt. Ltd.
  • Canada Drugs
  • DocMorris NV
  • Dr Fox Pharmacy
  • eDrugstore.com
  • Express Scripts Holding Company
  • Giant Eagle, Inc.
  • InternationalDrugMart.com
  • MediSave
  • Netmeds Marketplace Limited
  • OptumRx, Inc.
  • PlanetRx
  • Rowlands Pharmacy
  • The Kroger Company
  • Walgreen Co.,
  • Wal-Mart Stores, Inc.
  • Zur Rose Group AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • ePharmacy on the Roll Despite Stumbling Blocks
    • Recent Market Activity
    • Inherent Benefits of the Channel - A Key Driving Factor
    • Regulations - A Game Changer for the ePharmacy Market
    • Legal Status of Online Sale of Medications - Prescription and Non-Prescription in Select Markets
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
    • 1mg Technologies Pvt. Ltd. (India)
    • Canada Drugs (Canada)
    • Dr Fox Pharmacy (UK)
    • eDrugstore.com (USA)
    • Express Scripts Holding Company (USA)
    • Giant Eagle, Inc. (USA)
    • InternationalDrugMart.com (Cyprus)
    • Lloyds Pharmacy Ltd. (UK)
    • MediSave (Canada)
    • Netmeds Marketplace Limited (India)
    • OptumRx, Inc. (USA)
    • PlanetRx (UK)
    • Rowlands Pharmacy (UK)
    • Sanicare-Apotheke (Germany)
    • T.mall.com (China)
    • The Kroger Company (USA)
    • Walgreen Co. (USA)
    • Wal-Mart Stores, Inc. (USA)
    • Yihaodian (China)
    • Zur Rose Group AG (Switzerland)
    • DocMorris NV (Netherlands)
  • 3. MARKET TRENDS & DRIVERS
    • ePharmacies Bring Potential Value to Customers
    • ePharmacies Enable Better Care and Enhance Quality of Life
    • Prescription Drugs Fuel the Growth of Electronic Pharmacies
    • Increasing Healthcare Spending in Emerging Markets: Opportunities in Store
    • Ballooning Elderly Population: The Vital Growth Driver
    • Internet Globalizes Drug Sales through ePharmacies
    • Expanding Internet User Base: A Key Driving Force
    • Rising Smartphone Usage Supports Growing Adoption
    • Re-importation or Cross Border Drug Sales: An Area of Concern in the US
    • Cyber Crime in the Name of ePharmacies on the Rise
    • Online Pharmacies Growth Leads to Global Presence of Counterfeit Drugs
    • Perils of Counterfeit and Fake Drugs
    • Operation Pangea X - A Major Crackdown against Illegal Online Pharmacies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for ePharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for ePharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for ePharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Over-the-Counter Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Over-the-Counter Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Over-the-Counter Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Prescription Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Prescription Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Prescription Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 10: USA Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 11: USA Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 12: USA 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 13: Canada Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 14: Canada Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 15: Canada 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 16: Japan Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 17: Japan Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 18: Japan 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 19: China Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 20: China Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 21: China 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 22: Europe Current & Future Analysis for ePharmacies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 23: Europe Historic Review for ePharmacies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 24: Europe 15-Year Perspective for ePharmacies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 25: Europe Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 26: Europe Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 27: Europe 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 28: France Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 29: France Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 30: France 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 31: Germany Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 32: Germany Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 33: Germany 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 34: Italy Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 35: Italy Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 36: Italy 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 37: UK Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 38: UK Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 39: UK 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 40: Rest of Europe Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Rest of Europe Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 42: Rest of Europe 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 43: Asia-Pacific Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Asia-Pacific Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 45: Asia-Pacific 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 46: Rest of World Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 47: Rest of World Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 48: Rest of World 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 69
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.